Hyperion Biosystems
Founded in 2013 as an MIT spinout, Hyperion Biosystems develops diagnostic technologies leveraging computer vision, physics-based, and AI-enhanced algorithms. The company specializes in advancing sensitivity and specificity for point-of-care and at-home diagnostics, supporting rapid, multiplexed molecular detection, and contributing to authentication and anti-counterfeiting solutions in the pharmaceutical and nutraceutical sectors.
Industries
N/A
Products
A hardware-software integrated reader platform that boosts diagnostic assay sensitivity and specificity, compatible with rapid diagnostic assays.
Platform combining padlock probe chemistry, isothermal amplification, and optical readout to achieve highly multiplexed molecular target detection with single-copy sensitivity.
Technology for on-dose authentication to prevent counterfeiting of pharmaceutical and nutraceutical tablets and capsules.
A hardware-software integrated reader platform that boosts diagnostic assay sensitivity and specificity, compatible with rapid diagnostic assays.
Platform combining padlock probe chemistry, isothermal amplification, and optical readout to achieve highly multiplexed molecular target detection with single-copy sensitivity.
Technology for on-dose authentication to prevent counterfeiting of pharmaceutical and nutraceutical tablets and capsules.
Services
Integration of advanced algorithms into existing point-of-care and at-home diagnostic platforms to enhance performance metrics such as sensitivity and specificity without hardware redesign.
Service supporting labs to detect hundreds to thousands of molecular targets with high sensitivity using standard equipment, supported by platform technology.
Integration of advanced algorithms into existing point-of-care and at-home diagnostic platforms to enhance performance metrics such as sensitivity and specificity without hardware redesign.
Service supporting labs to detect hundreds to thousands of molecular targets with high sensitivity using standard equipment, supported by platform technology.
Expertise Areas
- Diagnostic assay development
- Digital health and connected diagnostics
- Computer vision in diagnostics
- Physics-based algorithm design
Key Technologies
- Computer vision algorithms
- Physics-based diagnostic algorithms
- AI-enhanced diagnostic software
- Isothermal amplification
Key People
Chief Executive Officer
VP Business Operations
Chief Technology Officer
VP Marketing
Chief Product Owner
Director of Product Development
Chief Executive Officer
VP Business Operations
Chief Technology Officer
VP Marketing
Chief Product Owner
Director of Product Development
News & Updates
Delivered custom diagnostic solutions in highly accelerated timeframes.
Achieved an average 10x increase in assay sensitivity using in-house algorithms.
Algorithms have powered over 10,000 diagnostic assay runs.
Describes the use of smartphone cameras for time-gated luminescence diagnostic measurements.
Article discussing the importance of governance in digital health and connected diagnostics.
Launched a multiplexed molecular diagnostic platform using padlock probe chemistry and isothermal amplification for simultaneous detection of hundreds to thousands of targets.
Delivered custom diagnostic solutions in highly accelerated timeframes.
Achieved an average 10x increase in assay sensitivity using in-house algorithms.
Algorithms have powered over 10,000 diagnostic assay runs.
Describes the use of smartphone cameras for time-gated luminescence diagnostic measurements.
Article discussing the importance of governance in digital health and connected diagnostics.
Launched a multiplexed molecular diagnostic platform using padlock probe chemistry and isothermal amplification for simultaneous detection of hundreds to thousands of targets.